Factor V Leiden mutation in cerebrovascular disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 3, 2005, Pages 339-342

  Buyru, Nur ^a   Altinisik, Julide ^a   Somay, Goksel ^b   Ulutin, Turgut ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE HOSPITAL   (Turkey)

Author keywords

Cerebrovascular disease; FV Leiden mutation; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GENE AMPLIFICATION; GENE MUTATION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK ASSESSMENT; SMOKING;

AGED; CARDIOVASCULAR DISEASES; DNA PRIMERS; FACTOR V; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; VENOUS THROMBOSIS;

EID: 22544467756     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100314     Document Type: Article

References (20)

1. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981;10:369.
2. Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism, a study in three Dutch families. N Engl J Med 1983;309:340.
3. Engesser L, Broekmans AW, Briet E, et al. Hereditary protein S deficiency: Clinical manifestations. Ann Intern Med 1987;106:677.
4. Esman CT. The protein C auticoagulant pathway. Arterioscler Thromb 1992;12:135.
5. Pabinger I, Kyrle PA, Heistinger M, et al. The risk of thromboembolism in patients with protein S or protein C deficiency: Prospective cohort study. Thromb Haemost 1994;71(4):441.
6. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95(5):1517.
7. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004.
8. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64.
9. 506→ Gln) mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912.
10. Ridker PM, Hennekens CH, Lindopainter K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912.
11. Lalouschek W, Aull S, Series W, Zeiler K. The protrombin G20210A mutation in patients with cerebrovascular disease. Blood 1998;92(2):704.
12. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994;72:352.
13. Dahlbäck B. Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 1999; 25:273.
14. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517.
15. Gurgey A. Clinical manifestations in thrombotic children with factor V Leiden mutation. Pediatr Hematol Oncol 1999;16:233.
16. Nowak-Götti U, Sträter R, Heinecke A, et al, for the Childhood Stroke Study Group. Lipoprotein(a) and genetic polymorphisms of clotting factor V, protrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94(11):3678.
17. Lynch JK, Nelson KB, Curry CJ, Grether JK. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001;16(10):735.
18. Pres RD, Liu X-Y, Beamer N, Coull BM. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated Protein C. Stroke 1996;27:44.
19. Catto A, Carter A, Ireland H, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscl Thromb Vasc Biol 1995;15:783.
20. Van der Bom JG, Bots ML, Haverkate F, et al. Reduced response to activated Protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 1996;125:265.